Medicine guide
Starjemza
45 mg/.5mL · Injection
- Prescription only
- Interleukin-12 Antagonist
- Active substance
- Ustekinumab-Hmny
- Made by
- Hikma Pharmaceuticals USA Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupCancer treatments and immune-system medicines
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Hikma Pharmaceuticals USA Inc. |
|---|---|
| Active substance | Ustekinumab-Hmny |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 45 mg/.5mL |
| Form | Injection |
| Route | Subcutaneous |
| Packs | .5 mL in 1 SYRINGE · .5 mL in 1 VIAL |
| NDC | 0143-9168 |
| NDC | 0143-9169 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Injection3 products
- 45 mg/.5mL
- 90 mg/mL
- 130 mg/26mL
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.